Fund Overlap

See which holdings any two equity ETFs have in common, along with top differences in exposure.


For overlap across multiple ETFs use Portfolio Builder   

15

Number of overlapping holdings

19.0%

% of CNCR's 81 holdings also in IDNA

35.7%

% of IDNA's 46 holdings also in CNCR

Overlap by Weight
Sector Drift (CNCR minus IDNA)
Overlapping Holdings

Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.


Company Weight
in CNCR
Weight
in IDNA
Overlap
BLUEPRINT MEDICINES CORP. 1.7% 5.6% 1.7%
IMMUNITYBIO INC 2.9% 1.4% 1.4%
MACROGENICS INC 2.0% 1.4% 1.4%
IOVANCE BIOTHERAPEUTICS INC 1.3% 3.0% 1.3%
EXELIXIS INC 1.2% 5.4% 1.2%

Position Highlights (Non-Overlapping Exposures)
CNCR Overweight Relative to IDNA
REVOLUTION MEDICINES, INC. 2.2%
MIRATI THERAPEUTICS INC 2.2%
ARCELLX, INC. 2.0%
AUTOLUS THERAPEUTICS PLC SPONSORED A 2.0%
NUVALENT, INC. CLASS A 1.7%
HUTCHISON CHINA MEDITECH LIMITED SPO 1.6%
RAIN THERAPEUTICS INC 1.6%
ZYMEWORKS INC. 1.5%
IMMUNITYBIO INC 1.5%
THESEUS PHARMACEUTICALS, INC. 1.5%
CNCR Underweight Relative to IDNA
CRISPR THERAPEUTICS AG -4.6%
SANOFI-AVENTIS -4.4%
TAKEDA PHARMACEUTICAL CO LTD -4.2%
BEAM THERAPEUTICS, INC. -4.2%
EXELIXIS INC -4.2%
TWIST BIOSCIENCE CORP. -4.1%
REGENERON PHARMACEUTICALS -4.0%
ROCHE HOLDING LTD -4.0%
BEIGENE, LTD. -3.9%
GENMAB A/S -3.9%
Flag icons made by Freepik from www.flaticon.com is licensed by CC 3.0 BY